- •Preface
- •Contents
- •List of Abbreviations
- •Antibacterial Agents
- •A. TOPICAL ANTIBIOTICS
- •B. ORAL ANTIBIOTICS
- •C. ANTIBIOTICS FOR SUBCONJUNCTIVAL/INTRAVITREAL INJECTION
- •D. REGIMENS FOR SPECIFIC ORGANISMS
- •E. REGIMENS FOR SPECIFIC CLINICAL ENTITIES
- •7 Dacryocystitis
- •Antifungal Agents
- •A. AGENTS
- •B. SPECIFIC ANTI-FUNGAL REGIMENS
- •2 Molds
- •3 Dimorphic Fungi
- •Antiviral Agents
- •A. TOPICAL
- •B. SYSTEMIC
- •Anti-Parasitic Agents
- •A. PROTOZOA
- •B. HELMINTHS
- •Anti-Glaucoma Agents
- •D. HYPEROSMOLAR AGENTS
- •H. COMBINATION AGENTS
- •I. SPECIFIC REGIMENTS
- •2 Elevated Eye Pressure During Pregnancy
- •Neuro-Ophthalmology
- •A. AGENTS USED IN NEURO-OPHTHALMOLOGY
- •B. SPECIFIC REGIMENS
- •Anti-Inflammatory Agents
- •A. STEROIDAL
- •B. COMBINATION STEROID WITH ANTIBIOTIC
- •C. NONSTEROIDAL
- •D. MISCELLANEOUS
- •Mydriatics, Cycloplegics, and Reversal Agents
- •Lubricants and Viscoelastics
- •A. ARTIFICIAL TEARS, VISCOELASTICS, AND LUBRICATING OINTMENTS
- •Low Viscosity
- •High Viscosity
- •Unknown Viscosity
- •Insert
- •Gels & Ointments
- •Ointments
- •Gels
- •Viscoelastics
- •B. IRRIGATING SOLUTIONS
- •Miscellaneous
- •A. AGENTS FOR RELIEF OF SEASONAL ALLERGIC CONJUNCTIVITIS/OCULAR DISCOMFORT
- •B. OCULAR DECONGESTANTS
- •C. TOPICAL HYPEROSMOLAR AGENTS
- •D. VITAMINS
- •E. ANESTHETIC AGENTS
- •F. HOMEOPATHIC DRUGS
- •G. CAPSULE STAINING ADJUNCTS
- •H. MISCELLANEOUS
- •I. DRUGS FOR HYPHEMA
- •Anti-Angiogenesis Agents
- •Contact Lens Solutions
- •Contact Lens Solution Hypersensitivity
- •Soft Contact Lens Solutions
- •I. LISTING OF SOFT LENS PRODUCTS BY CATEGORY
- •A. Daily Cleaners
- •B. Enzymatic Cleaners
- •C. Daily Protein Removers
- •D. Rewetting/Lubricating Drops
- •E. Oxidation Solutions/Systems
- •F. Saline Solutions
- •G. Combination Solutions
- •II. SOFT LENS PRODUCTS LISTED BY SYSTEM AND MANUFACTURER: NOT ALL PRODUCTS ARE LISTED IN THIS SECTION BECAUSE NOT ALL PRODUCTS BELONG TO A PARTICULAR SYSTEM
- •Rigid Lens Solutions
- •I. LISTING OF RIGID LENS RODUCTS BY CATEGORY
- •A. Daily Cleaners
- •C. Daily Protein Remover
- •D. Oxidation Systems
- •E. Storage and Disinfection
- •F. Wetting/Rewetting
- •G. Combination Solutions
- •APPENDIX 1: TOPICAL ANTIBACTERIAL SPECTRUM
- •APPENDIX 2: A PREPARING FORTIFIED TOPICAL ANTIBIOTICS AND PREPARING ORAL ACETAZOLAMIDE SOLUTION
- •Fortified Bacitracin
- •Fortified Cefazolin
- •Fortified Vancomycin
- •APPENDIX 3: ANTI-FUNGAL ACTIVITY SPECTRUM
- •APPENDIX 4: RENAL DOSING FOR SELECTED DRUGS
- •Cidofovir Dosing in Renal Failure*
- •Famciclovir Dosing in Renal Failure*
- •Foscarnet Dosing in Renal Failure*
- •Intravenous Ganciclovir Dosing in Renal Failure*
- •Oral Ganciclovir Dosing in Renal Failure*
- •Valacyclovir Dosing in Renal Failure*
- •APPENDIX 5: GLAUCOMA MEDICATION PRESERVATIVES
- •APPENDIX 6: TITRATING TOPICAL DROPS FOR CHILDREN
- •Product Index
- •Subject Index
B. ORAL ANTIBIOTICS
Drug |
Trade |
Dose |
Notes |
amoxicillin |
Amoxil, Polymox |
250–500 mg PO TID |
Adult Dose |
|
|
25–50 mg/kg/day PO in 3 divided doses |
Pediatric Dose |
amoxicillin/clavulanate |
Augmentin |
250–500 mg PO TID or 875 mg PO BID |
Adult Dose |
|
|
20–40 mg/kg/day PO in 3 divided doses |
Pediatric Dose |
azithromycin |
Zithromax |
500 mg PO day 1, then 250 mg QD 4 |
Adult Dose |
|
|
days |
|
|
|
20 mg/kg 1 (pediatric dose) |
Dose for Chlamydia conjunctivitis (Arch |
|
|
1000 mg PO 1 (adult dose) |
Ophthalmol 1998;116:1625–28 |
|
|
|
Ophthalmology 1998;105:658–61) |
|
|
5–12 mg/kg/day PO in one dose for 5 days |
Pediatric Dose |
cephalexin |
Keflex |
25–500 mg PO QID |
Adult Dose |
|
|
25–50 mg/kg/day PO in 4 divided doses |
Pediatric Dose |
cefuroxime axetil |
Ceftin |
250–500 mg PO BID |
Adult Dose |
|
|
20–30 mg/kg/day PO divided BID |
Pediatric Dose |
ciprofloxacin |
Cipro |
250–750 mg PO BID |
Not for children or pregnancy |
|
|
|
Do not take with antacids must modify |
|
|
|
dosage in renal failure |
|
Cipro XE |
500 mg PO QD |
Extended release formula |
clarithromycin |
Biaxin |
250–500 mg PO BID |
Adult Dose |
|
|
15 mg/kg/day PO divided BID |
Pediatric Dose |
|
|
|
|
|
|
|
(continued ) |
Antibacterial Agents 5
6
B. ORAL ANTIBIOTICS (continued )
Drug |
Trade |
Dose |
Notes |
doxycycline |
Vibramycin |
100 mg BID |
Can be used for ocular rosacea |
|
|
|
Not for children or pregnancy |
erythromycin |
E-mycin |
250–500 mg PO QID |
Adult Dose |
|
|
30–50 mg/kg/day in 3–4 divided doses |
Pediatric Dose |
gatifloxacin |
Avelox |
400 mg PO QD |
Not for children or pregnancy |
levofloxacin |
Levaquin |
500 mg PO QD |
Not for children or pregnancy; must |
|
|
|
modify dosage in renal failure |
minocycline |
Minocin |
100–200 mg PO BID |
Not for children or pregnancy |
moxifloxacin |
Tequin |
400 mg PO QD |
Not for children or pregnancy |
ofloxacin |
generic |
200–400 mg PO BID |
Not for children or pregnancy; must |
|
|
|
modify dosage in renal failure |
tetracycline |
Achromycin |
250–500 mg PO QID |
Can be used for ocular rosacea |
|
|
|
Not for children or pregnancy |
|
|
|
Do not take with food, milk products, or |
|
|
|
antacids |
|
|
|
|
C. ANTIBIOTICS FOR SUBCONJUNCTIVAL/INTRAVITREAL INJECTION |
|
||
|
Subconjunctival Injection |
Intravitreal Injection |
Notes |
(1) AminoglycosidesC |
|
|
|
amikacin |
25 mg |
0.2–0.4 mg |
|
gentamicin |
10–20 mg |
0.2–0.4 mg |
|
kanamycin |
30 mg |
N/A |
|
neomycin |
125–250 mg |
N/A |
rarely used |
tobramycin |
10–20 mg |
0.1–0.4 mg |
|
(2) Penicillins |
|
|
|
ampicillin |
50–150 mg |
0.5 mg |
rarely used |
carbenicillin |
100 mg |
0.25–2.0 mg |
|
methicillin |
50–100 mg |
1.0–2.0 mg |
|
penicillin G |
0.5–1.0 million units |
N/A |
|
ticarcillin |
100 mg |
N/A |
|
(3) Cephalosporins |
|
|
|
cefazolin |
100 mg |
2.0–2.25 mg |
1st Generation, rarely used |
ceftazidime |
200 mg |
2.25 mg |
3rd Generation |
|
|
|
|
(continued )
Antibacterial Agents 7
